Summary
GBI Research, a leading
business intelligence provider, has released its latest research report,
"Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance
Treatment Segmentation and Drive Growth in an Increasingly Competitive Market".
The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to
increase significantly over the forecast period across the leading eight
developed nations, from $5.1 billion in 2013 to $7.9 billion in 2020. This
equates to a Compound Annual Growth Rate (CAGR) of 6.6%. Growth will be driven
by novel therapies entering the squamous cell carcinoma market segment, which
is currently lacking effective treatment, unlike the non-squamous market
segment.
Click for report details:
http://www.radiantinsights.com/research/non-small-cell-lung-cancer-market-to-2020-new-therapies-to-enhance-treatment-segmentation-and-drive-growth-in-an-increasingly-competitive-market
The report focuses on
the increasing differentiation between the three main NSCLC subtypes: squamous
cell, adenocarcinoma, and large cell carcinoma. Common genetic and molecular
aberrations within these histologies are being extensively researched and
targeted by novel therapeutics and so the treatment algorithm between
histological subtypes is forecast to become more differentiated over the
forecast period. Most notably, patients with squamous cell carcinoma are set to
benefit from crucial first- and second-line therapies in the form of Yervoy
(ipilimumab) and nivolumab, having relied on generic chemotherapy for the past
decade.
Non-squamous patients,
on the other hand, have several successful histology-specific therapies, such
as Alimta (pemetrexed), and mutation-specific therapies, such as Tarceva
(erlotinib), that are already marketed. New second-line entrants will create a
crowded and competitive environment. The generic erosion of market leaders
Alimta and Tarceva late in the forecast period will make this a tough
environment for new products that have shown only minor improvements in safety
or efficacy.
About Radiant Insights
Radiant Insights is a platform for companies looking to meet
their market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports, helping
them in the decision making process. We have a comprehensive collection of
reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For More Information Visit – Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
No comments:
Post a Comment